Hernexeos (zongertinib)

HER2 TKI for lung cancer

SKU: hernexeos-zongertinib Category: Lung Cancer Tags: her2, lung-cancer, nsclc, oncology, tkI

Description

Hernexeos (zongertinib) is a HER2-selective tyrosine kinase inhibitor for HER2-mutant non-small cell lung cancer.

There are no reviews yet.

Be the first to review “Hernexeos (zongertinib)”